2026 NPPES data Internal Medicine Physician NPI 1407956378 M.D.
Verify on CMS →

Paris Spanolios, M.D.

Internal Medicine Physician in Milford, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
7K
Medicare Part D claims · 632 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
94.2/100
▲ 11 pts above national avg 83.1 · [object Object]
Industry payments
$657.7
12 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Paris Spanolios, M.D. reported a CMS MIPS final score of 94.2/100 — above the 83.1 national average — and filed 7,198 Medicare Part D claims in 2023.

94.2/100
MIPS score · +11 vs avg
7K
Part D claims, 2023
87%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

Paris Spanolios, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

94 Top 25% higher than 75% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

Paris Spanolios, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Paris Spanolios, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 09/22/2006

NPI 1407956378

Primary specialty

Internal Medicine Physician

High-volume

172,858 US NPIs in this specialty

Medicare Part D claims

7,198 165% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

MIPS final score

94.2/100 11.1 pts vs avg

Exceptional band

vs 83.1 national avg

Specialty distribution in Connecticut

How Internal Medicine Physician compares to other specialties among Connecticut providers

Connecticut providers

Internal Medicine Physician share within Connecticut

1. Internal Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Internal Medicine Physician share within Connecticut

Medicare quality performance — MIPS

Paris Spanolios, M.D.'s 2023 MIPS final score plotted against the Internal Medicine Physician national average

High performer (top quartile)
MIPS Final Score
94.2/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Internal Medicine Physician) — 94.2/100 vs national avg 83.1

0%100%National avg83%94.2%
MIPS final score (Internal Medicine Physician) — 94.2/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Paris Spanolios, M.D. appears in the CMS NPPES registry as a Internal Medicine Physician provider holding M.D. credentials at 40 COMMERCE PARK, Milford, CT, 06460, with a listed phone of (203) 878-3531. NPI 1407956378 was issued on 09/22/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Spanolios most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 7,198 prescription claims written by this provider, covering 632 Medicare beneficiaries and totaling roughly $1.0 million in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 0.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.2/100 for the 2023 performance year (Quality 81.9), compared with the national average of 83.1.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

40 COMMERCE PARK
Milford, CT 06460

Provider Details

NPI 1407956378
Specialty Internal Medicine Physician
Credentials M.D.
Gender Male
NPI Issued 09/22/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

94.1777
Final Score
Avg: 83.1
81.9442
Quality
99.3986
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where Paris Spanolios, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Internal Medicine OF Milford PC
Milford, CT

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Paris Spanolios, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$658

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

Paris Spanolios, M.D. — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 7,198 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

7,198
Total Claims
$1.0M
Total Drug Cost
632
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
17,743
Total Day Supply
522,187
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$875K
Generic Drug Cost
$136K
Opioid Claims
40 (0.6% rate)
Antibiotic Claims
219

Patient Demographics

Average Patient Age
74.4 years
Avg HCC Risk Score
0.98
Gender Split
52% female / 48% male
Age Distribution
<65: 16, 65-74: 328, 75-84: 220, 85+: 68

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Paris Spanolios, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
582
Rosuvastatin Calcium
454
Lisinopril
432
Amlodipine Besylate
347
Levothyroxine Sodium
343
Losartan Potassium
163
Metformin Hcl Er
Metformin Hcl
162
Hydrochlorothiazide
149
Pravastatin Sodium
128
Simvastatin
121

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How Paris Spanolios, M.D. fits within the Internal Medicine Physician landscape nationally.

172,858
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

Paris Spanolios, M.D.'s 7,198 claims are above the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as Spanolios.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Connecticut medical board — federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Internal Medicine Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Paris Spanolios, M.D.'s specialty?
Paris Spanolios, M.D. specializes in Internal Medicine Physician and practices in Milford, Connecticut. Credentials: M.D..
How much does Paris Spanolios, M.D. prescribe under Medicare Part D?
In 2023, Paris Spanolios, M.D. wrote 7,198 Medicare Part D claims totaling $1.0M in drug costs for 632 beneficiaries.
What is Paris Spanolios, M.D.'s Medicare quality score?
Paris Spanolios, M.D. has a CMS MIPS Final Score of 94.2/100 (Quality: 81.9). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Paris Spanolios, M.D. located?
Paris Spanolios, M.D. is located at 40 COMMERCE PARK, Milford, CT, 06460. Phone: (203) 878-3531.
What is Paris Spanolios, M.D.'s NPI number?
Paris Spanolios, M.D.'s National Provider Identifier (NPI) is 1407956378, issued on 09/22/2006.
Does Paris Spanolios, M.D. prescribe more brand-name or generic drugs?
Paris Spanolios, M.D.'s prescribing is 13% brand-name and 87% generic drugs by claim count, with $875K in brand drug costs.
Does Paris Spanolios, M.D. prescribe opioids?
Yes, Paris Spanolios, M.D. had 40 opioid claims in 2023 with an opioid prescribing rate of 0.6%.
How many Internal Medicine Physician providers are there in the US?
There are 172,858 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does Paris Spanolios, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Paris Spanolios, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Rosuvastatin Calcium, Lisinopril. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Paris Spanolios, M.D. accept Medicare?
Paris Spanolios, M.D. appears in CMS Medicare data with 7,198 Part D claims and 632 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Paris Spanolios, M.D.'s credentials?
Paris Spanolios, M.D.'s NPI is 1407956378 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology